Cytek Biosciences Inc (nasdaq:CTKB) Share Price

Company Profile

Business description
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Contact
47215 Lakeview Boulevard
FremontCA94538
USA
T: +1 877 922-9835
https://www.cytekbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
702

Recommended

Stocks that had been posting triple-digit returns are sliding on earnings results.

Karen Gilchrist | 12 August 2026

Shares still overvalued, with analysts thinking the fundamentals no longer matter to the share price.

Nathan Zaia | 12 August 2026

The “SaaSpocalypse” never arrived. Now, software stocks are positioning for a long-awaited comeback.

Tyger Fitzpatrick | 12 August 2026

Index	Last price	Change	% Change
All Ordinaries	9,381.40	9.10	-0.10%
CAC 40	8,663.50	11.44	-0.13%
DAX 40	26,368.24	37.17	0.14%
Dow JONES (US)	53,960.05	189.78	0.35%
FTSE 100	10,785.44	47.71	-0.44%
HKSE	25,396.51	43.66	-0.17%
NASDAQ	26,847.50	259.01	0.97%
Nikkei 225	68,308.59	784.53	1.16%
NZX 50 Index	13,825.30	87.64	0.64%
S&P 500	7,807.85	59.35	0.77%
S&P/ASX 200	9,188.50	4.40	-0.05%
SSE Composite Index	3,926.96	19.71	-0.50%